Slovakia’s National Anti-Drug Strategy (2013-20), adopted in 2013, addresses illicit drug problems. It is built around two pillars addressing (i) demand and (ii) supply reduction, and three cross-cutting themes focused on (i) coordination, (ii) international cooperation and (iii) research, information, monitoring and evaluation. The strategy mirrors the approach taken at the European Union level. It builds on an awareness of current drug problems, including poly-substance use, stimulant (including methamphetamine) use, the need to control medications containing psychoactive or drug precursor ingredients, the challenges posed by blood-borne viruses (such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV)), the need for improved treatment service coverage and the changing dynamics of the drug markets. The overall aim is to contribute to drug demand reduction and drug supply reduction, as well as the reduction of health and social risks and harms caused by drugs. These issues are addressed through the strategy’s five top-level objectives.
Like other European countries, Slovakia evaluates its drug policy and strategy using routine indicator monitoring and specific research projects. A final internal evaluation of the implementation of the National Anti-Drug Strategy (2009-12) was previously undertaken and used in the development of the current strategy. Progress on the current strategy’s implementation is reported annually.
Focus of national drug strategy documents: illicit drugs or broader
NBYear of data 2015. Strategies with broader focus may include, for example, licit drugs and other addictions.
Chaired by the Minister for Health, the Government Council for Drug Policy is responsible for interministerial coordination and comprises representatives from all relevant ministries. It advises the government, develops and implements drug strategies, proposes financial arrangements for drug policy issues, and suggests responses to serious drug problems. The Council is also involved in the drafting of drug-related legislation, coordinating Slovakia’s obligations under international drug control treaties, and liaising with international organisations. The Department of Drug Strategy Coordination and Monitoring of Drugs is based within the Ministry of Health. It functions as the Council’s Secretariat and oversees the strategic and operational coordination and implementation of the National Drugs Strategy. The Department is the responsibility of the Director General of the Health Section at the Ministry of Health. The Department’s Director also functions as the Secretary of the Council. The Department of Drug Strategy Coordination and Monitoring of Drugs consists of two sections. The National Drugs Strategy section is tasked with national coordination and implementation of the National Anti-Drugs Strategy. It also includes a unit dealing with institutional and international relations and information transfers related to drug issues. The National Monitoring Centre for Drugs section functions as Slovakia’s national focal point. It is responsible for monitoring the drug situation and managing national drug information systems. Regional coordinators for the prevention of criminality address illicit drug issues at a local level.